Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides

Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides

Item

http://www.wikidata.org/entity/Q28368747

Q28368747

about

Pneumocystis Pneumonia in Human Immunodeficiency Virus-infected Adults and Adolescents: Current Concepts and Future Directions Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective Characterization of nebulized buparvaquone nanosuspensions--effect of nebulization technology.HIV: primary and secondary prophylaxis for opportunistic infections.Antiparasitic agent atovaquone Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients.Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation.Management of Pneumocystis Jirovecii pneumonia in HIV infected patients: current options, challenges and future directions.2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)Imidazoquines as antimalarial and antipneumocystis agents.Consensus summary of aerosolized antimicrobial agents: application of guideline criteria. Insights from the Society of Infectious Diseases Pharmacists.Intravenous pentamidine for Pneumocystis carinii/jiroveci pneumonia prophylaxis in pediatric transplant patients.Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.Molecular basis for atovaquone resistance in Pneumocystis jirovecii modeled in the cytochrome bc(1) complex of Saccharomyces cerevisiae.Acute hemolysis in a patient with a newly diagnosed glioblastoma.Plasma concentrations of atovaquone given to immunocompromised patients to prevent Pneumocystis jirovecii.

P2860

Q26795592-AA2A2FC9-4B7D-40B9-8CF4-BDA0E1810378 Q26822988-70444806-981F-4274-A506-7E5B15759E7D Q28388806-72EE1EE7-BA30-472E-A65E-5DD9877F7BC4 Q33228693-9194C211-8B2E-4792-BDBC-02B8BAD37E2D Q33850498-234E26C5-B60C-4FBA-B147-26B4A6F94547 Q34107885-55897E34-B380-4BA5-B2B1-C9197A6F445F Q34212799-62A97994-739A-48AA-AE0B-E802116C60FE Q34754990-0D09E5E5-2075-4466-AB6F-153DB2EC25A5 Q34830142-C49573C5-A04B-476A-AEA7-BD1760822A68 Q35557252-510645A3-6ABC-4B87-83F5-E96CDDB81B9C Q35614631-5907FFB0-4F44-4A2D-BE3D-4D5FD3C9766A Q35920640-E2528AE6-42BA-4D02-BAEC-146DE4B7368C Q37150434-83C0E337-5D12-4693-8A7D-DA486DF650A6 Q37180338-4E1A5B79-1550-419A-8D16-DB06583CE7CB Q37459170-8E18743F-F8A2-463D-A197-A32E59572393 Q37760514-7FFA8BF4-4F44-4EF9-9D43-79CDDD503D89 Q38364906-0031D653-3970-4D3B-8CF4-5EB7ADD8EC1F Q38647546-0263FF12-3973-47AC-8E83-B73A6CAB82C7 Q38934525-818FFAE5-22C0-4180-BE5E-DF2DCBB6289D Q40092648-59754891-869B-473B-AAC6-C2D271589E7A Q44616568-ABE88825-C00B-4957-B8D6-C6218F86EA39 Q44630376-A6AC7CE6-2352-4853-BCBA-1CF27B2B5F17 Q48711377-D88920D3-4A19-49EA-8D51-156BD6F287E7 Q54432895-F17D9F15-54AD-478F-979B-33C127BC97D1

P2860

Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides

Item

http://www.wikidata.org/entity/Q28368747

description

1999 nî lūn-bûn

@nan

1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu